✦ LIBER ✦

In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832

✍ Scribed by J. Jaen; S. Barrett; M. Brann; M. Callahan; R. Davis; P. Doyle; D. Eubanks; D. Lauffer; L. Lauffer; W. Lipinski; D. Moreland; C. Nelson; C. Raby; R. Schwarz; C. Spencer; H. Tecle

Book ID: 118347252
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 732 KB
Volume: 56
Category: Article
ISSN: 0024-3205
DOI: 10.1016/0024-3205(95)00019-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of M1 subtype selective musc

Development of M1 subtype selective muscarinic agonists for Alzheimer's disease: Translation of in vitro selectivity into in vivo efficacy

✍ R.D. Schwarz; M.J. Callahan; R.E. Davis; J.C. Jaen; H. Tecle 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Clinical trials in Alzheimer's disease (AD) with first generation muscarinic agonists (e.g., arecoline, oxotremorine, pilocarpine) produced inconsistent results due to poor pharmacokinetic properties and a lack of separation between central and peripheral activities observed with these compounds. Se

In vitro and in vivo m2 muscarinic subty

In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones

✍ Victor I Cohen; Biyun Jin; R.Carter McRee; Sheila F Boulay; Emil I Cohen; Virend 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 916 KB

Xanomeline: A potent and selective M1 mu

Xanomeline: A potent and selective M1 muscarinic agonist in vitro

✍ Mitch, CH; Bymaster, FP; Calligaro, DO; Quimby, SJ; Sawyer, BD; Shannon, HE; War 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Comparison of the in vitro and in vivo p

Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists

✍ Per-Göran Gillberg; Staffan Sundquist; Lisbeth Nilvebrant 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Subtypes of muscarinic receptors in cani

Subtypes of muscarinic receptors in canine pancreatic secretion in vivo and in vitro

✍ Stanisław J. Konturek; Jolanta Jaworek; Janina Tasler; Marek Cieszkowski; Noboru 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 728 KB

The design of novel muscarinic partial a

The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo

✍ Stephen B. Freedman; Gerard R. Dawson; Leslie L. Iversen; Raymond Baker; Richard 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 399 KB